Company / Named in our posts
Virios Therapeutics, Inc..
Follow Virios Therapeutics, Inc.Development-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral-triggered abnormal immune response, such as fibromyalgia and Long-COVID.[1]
01Deal
Deals on Carrywatch
Every deal that names Virios Therapeutics, Inc., and its role in each.
Virios Therapeutics, Inc. / Pharmagesic (Holdings) Inc.
Virios Therapeutics combines with Pharmagesic (Holdings) Inc.
See deal detailsDeal Web
Virios Therapeutics, Inc. and 0 firms it shares a posted deal with, and the path to any other firm.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc.
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
- 02Form 8-K
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming Virios Therapeutics, Inc.:
- P01